Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2004);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;21191;Pharmacological Reviews;journal;15210081, 00316997;12.836;Q1;241;21;74;6688;2042;72;23.27;318.48;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
2;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.425;Q1;210;23;81;3391;1941;81;22.9;147.43;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;8.115;Q1;348;317;492;7006;3196;170;6.5;22.1;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.91;Q1;66;14;32;1993;244;32;8.04;142.36;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;3.825;Q1;225;117;489;5609;3243;392;7.41;47.94;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;3.779;Q1;211;55;183;9408;1620;180;7.82;171.05;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.348;Q1;134;25;83;3875;771;83;9.18;155;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.027;Q1;233;275;615;23250;3378;606;5.06;84.55;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;145164;Human Genomics;journal;14739542, 14797364;2.98;Q1;59;36;7;587;11;7;1.57;16.31;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
10;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.818;Q1;190;221;434;7600;2159;414;4.62;34.39;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
11;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;2.753;Q1;331;119;379;9608;3195;337;7.84;80.74;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
12;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.657;Q1;202;357;1027;14024;5866;1027;5.3;39.28;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
13;26371;Natural Product Reports;journal;02650568, 14604752;2.451;Q1;188;46;120;7652;856;118;7.01;166.35;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
14;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.441;Q1;115;84;172;4678;847;170;4.72;55.69;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Cell Biology (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
15;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;2.377;-;144;101;292;3620;2028;278;6.34;35.84;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
16;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.241;Q1;227;250;659;13878;3276;620;4.74;55.51;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
17;82448;Mutation Research - DNA Repair;journal;09218777;2.218;Q1;75;0;79;0;307;78;0;0;Netherlands;Western Europe;Elsevier BV;1989-2001;"Genetics (Q1); Molecular Biology (Q1); Toxicology (Q1)"
18;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.211;Q1;96;53;75;6918;413;73;5.56;130.53;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
19;12611;Drug Resistance Updates;journal;13687646, 15322084;2.198;Q1;119;30;99;2901;535;89;5.46;96.7;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;18148;Pain;journal;18726623, 03043959;2.107;Q1;269;345;788;13158;3982;736;4.38;38.14;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
21;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.049;Q1;146;97;327;5520;1267;297;3.74;56.91;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
22;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.009;Q1;139;100;307;4894;1445;282;4.93;48.94;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
23;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.958;Q1;276;741;1724;29138;9055;1709;5.26;39.32;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
24;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;1.929;Q1;269;813;2083;24447;10486;1993;4.85;30.07;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.918;Q1;233;601;1813;22625;8784;1813;4.68;37.65;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
26;20435;Neuropharmacology;journal;00283908, 18737064;1.901;Q1;176;261;696;13239;2845;696;4.01;50.72;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
27;12455;Molecular Therapy;journal;15250024, 15250016;1.856;Q1;185;232;689;9264;3444;595;4.7;39.93;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Molecular Biology (Q2)"
28;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.837;Q1;76;33;170;1358;649;168;3.97;41.15;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Biochemistry (Q1); Pharmacology (Q1); Physiology (Q1); Cell Biology (Q2)"
29;21782;Psychopharmacology;journal;00333158, 14322072;1.798;Q1;202;370;997;18890;3976;948;3.62;51.05;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
30;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.749;Q1;120;296;300;9401;758;211;2.53;31.76;United States;Northern America;Landes Bioscience;2002-2021;"Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
31;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.729;Q1;100;49;98;4262;486;93;5.19;86.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cancer Research (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
32;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.682;Q1;183;219;463;26553;2215;434;4.23;121.25;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
33;23916;Environmental Pollution;journal;02697491, 18736424;1.672;Q1;249;282;830;10872;2244;826;2.45;38.55;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
34;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.651;Q1;122;136;223;12967;1081;221;4.93;95.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
35;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.638;Q1;36;7;27;1827;95;23;2.79;261;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
36;21790;Antiviral Therapy;journal;20402058, 13596535;1.624;Q1;89;118;164;4626;631;157;3.67;39.2;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
37;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.624;Q1;182;213;688;6816;2867;676;4.1;32;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
38;26795;Controlled Clinical Trials;journal;01972456;1.623;Q1;74;47;211;1406;465;181;2.15;29.91;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
39;20663;Current Drug Metabolism;journal;18755453, 13892002;1.612;Q1;111;43;105;6141;491;99;4.73;142.81;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
40;20664;Current Drug Targets;journal;18735592, 13894501;1.608;Q1;107;70;131;7347;494;121;3.73;104.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
41;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.578;Q1;169;73;250;6098;1584;246;6.52;83.53;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
42;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.554;Q1;90;44;82;6719;369;82;4.5;152.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
43;26380;Drug and Alcohol Dependence;journal;03768716;1.533;Q1;173;148;419;6289;1477;410;3.34;42.49;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
44;23010;Journal of Controlled Release;journal;18734995, 01683659;1.485;Q1;282;296;770;9752;3408;767;3.93;32.95;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
45;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.48;Q1;129;99;317;3672;928;309;2.79;37.09;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
46;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.467;Q1;223;414;1676;18670;5876;1639;3.36;45.1;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
47;26512;Tetrahedron;journal;14645416, 00404020;1.466;Q1;226;1211;3300;52315;9848;3286;2.83;43.2;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
48;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.453;Q1;100;47;69;4162;329;67;4.61;88.55;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
49;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.435;Q1;203;465;1265;11630;4615;1023;3.72;25.01;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
50;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;1.428;Q1;43;17;27;290;93;27;3.44;17.06;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
51;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.427;Q1;97;50;113;1757;425;100;3.53;35.14;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
52;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.418;Q1;115;150;398;5725;833;397;1.89;38.17;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
53;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.415;Q1;166;352;562;39175;2791;485;5.13;111.29;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
54;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.398;Q1;206;475;1284;21122;4517;1241;3.56;44.47;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
55;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.376;Q1;177;185;477;6695;1939;473;4.04;36.19;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
56;29682;Receptors and Channels;journal;10606823;1.369;Q1;42;19;92;868;279;85;3.28;45.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Endocrinology (Q1); Pharmacology (Q1); Cell Biology (Q2)"
57;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.342;Q1;163;197;576;9101;1982;574;2.93;46.2;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
58;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.338;Q1;113;70;155;2716;476;138;2.95;38.8;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
59;25218;Toxicological Sciences;journal;10960929, 10966080;1.314;Q1;193;297;777;11408;2524;744;3.31;38.41;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
60;26514;Tetrahedron Letters;journal;00404039, 18733581;1.3;Q1;173;2123;6648;56322;17506;6647;2.69;26.53;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
61;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.291;Q1;159;267;850;12422;2497;846;2.6;46.52;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
62;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.284;Q1;90;58;174;2214;582;151;3.32;38.17;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
63;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.255;Q1;78;117;319;2164;583;297;1.72;18.5;United States;Northern America;Preston Publications;1977-2021;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
64;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.24;Q1;76;12;44;1900;171;43;3.57;158.33;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
65;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.229;Q1;70;30;134;1201;477;128;4.07;40.03;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
66;21237;Drug Safety;journal;01145916, 11791942;1.211;Q1;131;94;264;6299;1147;253;4.1;67.01;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
67;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;1.206;Q1;195;140;784;4857;2619;707;5.73;34.69;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
68;61687;Antiviral Chemistry and Chemotherapy, Supplement;journal;13502816;1.195;Q1;11;0;17;0;68;17;0;0;Switzerland;Western Europe;World Health Organization;1993-1995, 1997, 2001;"Pharmacology (Q1); Virology (Q1)"
69;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.182;Q1;81;78;269;4338;909;252;3.77;55.62;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
70;21687;American Journal of PharmacoGenomics;journal;11752203;1.175;Q1;38;38;94;2728;302;93;3.46;71.79;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
71;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.175;Q1;66;87;263;4579;812;240;3.19;52.63;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
72;22378;Vascular Pharmacology;journal;18793649, 15371891;1.167;Q1;100;36;124;1200;321;119;2.61;33.33;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
73;24763;Addictive Behaviors;journal;03064603;1.165;Q1;135;191;289;4594;650;288;2.09;24.05;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
74;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.131;Q1;175;243;612;14599;1880;598;2.74;60.08;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
75;19617;Antiviral Research;journal;01663542, 18729096;1.113;Q1;134;92;255;3664;914;253;3.56;39.83;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
76;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.099;Q1;213;294;802;9797;2371;798;2.74;33.32;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
77;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.078;Q1;109;136;644;11132;2214;621;4.19;81.85;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
78;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.072;Q1;96;74;143;2269;323;143;1.81;30.66;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
79;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.068;Q1;89;18;32;2144;94;31;3.09;119.11;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
80;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.063;Q1;104;60;206;2287;667;206;3.01;38.12;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
81;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.054;Q1;94;159;242;7732;941;236;3.6;48.63;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
82;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.045;Q1;229;426;1226;11101;3121;1219;2.37;26.06;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
83;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.037;Q1;118;87;247;3719;710;245;2.54;42.75;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2); Neurology (Q2)"
84;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.033;Q1;95;35;140;1336;264;140;1.8;38.17;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
85;22072;Current Gene Therapy;journal;18755631, 15665232;1.032;Q1;75;40;98;4309;409;98;4.23;107.73;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
86;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.03;Q1;139;283;850;12728;2201;845;2.73;44.98;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Biochemistry (Q2); Biological Psychiatry (Q2); Behavioral Neuroscience (Q3)"
87;21841;Food Additives and Contaminants;journal;0265203X, 14645122;1.026;Q1;102;127;432;3757;799;424;1.7;29.58;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
88;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;1.024;Q1;85;268;964;8920;1964;964;1.95;33.28;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q1); Inorganic Chemistry (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
89;23053;Journal of Natural Products;journal;01633864, 15206025;1.015;Q1;147;440;1199;11115;2750;1195;2.4;25.26;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Analytical Chemistry (Q2); Molecular Medicine (Q2)"
90;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.009;Q1;140;203;563;7660;1960;478;3.32;37.73;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;25240;Toxicology Letters;journal;03784274, 18793169;1.007;Q1;150;308;728;10463;2070;710;2.73;33.97;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
92;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.004;Q1;117;13;72;2428;228;71;3.86;186.77;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
93;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.998;Q1;72;51;157;1620;372;157;2.03;31.76;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
94;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.996;Q1;186;286;711;8970;1847;703;2.35;31.36;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
95;21333;European Journal of Pharmacology;journal;00142999, 18790712;0.989;Q1;189;775;2292;31548;6163;2286;2.68;40.71;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
96;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;0.988;Q1;134;163;443;8000;1193;437;2.69;49.08;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
97;25219;Toxicology;journal;0300483X, 18793185;0.979;Q1;165;260;805;9558;2297;789;3;36.76;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
98;22319;Toxicon;journal;18793150, 00410101;0.966;Q1;133;219;670;8189;1517;662;1.91;37.39;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q1)
99;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.956;Q1;55;31;90;2811;284;85;3.19;90.68;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q3)"
100;21167;Pharmacogenomics;journal;14622416, 17448042;0.933;Q1;94;98;219;4704;570;188;2.55;48;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q1); Genetics (Q3); Molecular Medicine (Q3)"
101;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;0.93;Q1;94;54;162;4953;363;155;2.58;91.72;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Drug Discovery (Q2); Molecular Medicine (Q3)"
102;22477;Investigational New Drugs;journal;01676997, 15730646;0.929;Q1;90;51;140;1478;344;137;2.21;28.98;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
103;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;0.928;Q1;91;170;292;13679;796;280;2.58;80.46;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Drug Discovery (Q2)"
104;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.927;Q1;154;1178;2458;26805;6195;2454;2.55;22.75;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
105;23109;Journal of Psychopharmacology;journal;14617285, 02698811;0.923;Q1;121;81;188;3428;463;173;2.17;42.32;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
106;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.92;Q1;114;167;462;5138;1116;461;2.4;30.77;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
107;25075;Ecotoxicology;journal;09639292, 15733017;0.915;Q1;97;65;134;2423;198;126;1.11;37.28;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
108;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;0.911;Q1;168;138;274;5437;602;271;2.26;39.4;Netherlands;Western Europe;Elsevier;1991-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Biotechnology (Q2)"
109;21165;PharmacoEconomics;journal;11707690, 11792027;0.907;Q1;104;121;318;5062;943;307;2.64;41.83;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
110;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.904;Q2;153;219;590;5397;1655;516;2.56;24.64;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
111;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;0.902;Q2;79;68;166;1724;428;160;2.58;25.35;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
112;20026;BMC Clinical Pharmacology;journal;14726904;0.897;Q2;39;6;16;212;33;16;1.33;35.33;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
113;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.88;Q2;83;67;209;3117;418;199;2.04;46.52;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Psychiatry and Mental Health (Q1); Pharmacology (Q2)"
114;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.877;Q1;183;209;505;8623;1286;491;2.59;41.26;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
115;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.875;Q2;113;137;425;5335;846;420;1.92;38.94;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
116;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.875;Q1;144;161;378;5034;940;364;2.14;31.27;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
117;18073;NeuroToxicology;journal;18729711, 0161813X;0.872;Q2;122;99;242;5035;580;241;2.59;50.86;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
118;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;0.856;Q2;51;57;53;5459;143;53;2.7;95.77;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
119;20473;Life Sciences;journal;18790631, 00243205;0.856;Q1;174;536;1696;20203;4162;1695;2.43;37.69;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
120;21196;Drug Discovery Today;journal;18785832, 13596446;0.851;Q2;185;271;930;4990;2134;716;2.69;18.41;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
121;14805;Steroids;journal;0039128X, 18785867;0.849;Q2;107;103;373;3356;899;370;2.54;32.58;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
122;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.833;Q2;93;136;468;5881;978;466;2.06;43.24;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
123;22432;International Immunopharmacology;journal;18781705, 15675769;0.83;Q2;119;176;558;6732;1384;554;2.12;38.25;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
124;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.83;Q2;103;80;211;3703;489;195;2.3;46.29;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Developmental Neuroscience (Q3); Cellular and Molecular Neuroscience (Q4)"
125;16948;Chirality;journal;1520636X, 08990042;0.822;Q2;80;95;380;2787;718;373;2.09;29.34;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
126;24652;Chemico-Biological Interactions;journal;00092797;0.82;Q2;128;87;486;3757;993;481;2.86;43.18;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
127;29053;Molecular Diversity;journal;1573501X, 13811991;0.813;Q2;58;46;70;1667;119;66;1.7;36.24;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
128;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.811;Q1;171;610;1330;20849;3019;1328;2.21;34.18;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
129;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;0.81;Q1;133;379;1288;8583;2210;1286;1.73;22.65;Netherlands;Western Europe;Elsevier;1983-2022;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
130;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.809;Q2;96;132;401;4689;926;397;2.31;35.52;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
131;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.796;Q2;80;64;191;1837;491;174;2.37;28.7;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
132;20104;CNS Drug Reviews;journal;1080563X, 15273458;0.793;Q2;61;23;72;1705;215;72;2.85;74.13;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q2); Pharmacology (Q2)"
133;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;0.79;Q1;88;62;94;4150;236;87;2.58;66.94;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
134;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.789;Q2;103;95;288;3004;650;271;1.96;31.62;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
135;21744;Planta Medica;journal;14390221, 00320943;0.788;Q1;122;255;800;4751;1545;798;1.75;18.63;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
136;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;0.78;Q2;79;158;449;7594;1145;418;2.63;48.06;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
137;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.775;Q2;95;99;163;8998;366;163;2.2;90.89;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
138;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.773;Q2;107;180;550;5535;1050;545;1.8;30.75;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
139;15840;Journal of Antibiotics;journal;00218820, 18811469;0.773;Q2;84;112;440;1752;646;368;1.45;15.64;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
140;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.772;Q1;81;70;201;1483;366;200;1.78;21.19;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
141;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.766;Q2;104;338;721;9332;1348;714;1.77;27.61;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
142;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.766;Q2;205;332;668;9722;1285;660;1.73;29.28;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
143;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.765;Q2;66;76;203;4069;450;187;2.19;53.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
144;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.753;Q2;96;119;336;3278;968;320;3.07;27.55;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
145;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.747;Q2;56;33;90;1430;171;86;1.71;43.33;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
146;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.744;Q2;114;137;464;3671;1126;438;2.4;26.8;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
147;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.743;Q2;62;37;126;1281;238;125;1.54;34.62;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
148;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.741;Q1;66;117;153;4033;437;152;2.91;34.47;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
149;20051;BioDrugs;journal;11738804, 1179190X;0.737;Q2;71;35;172;3364;466;167;2.25;96.11;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
150;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.732;Q2;90;82;147;2847;271;146;1.62;34.72;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
151;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.723;Q2;175;115;300;3234;656;299;1.86;28.12;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
152;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;0.722;Q2;121;146;468;5026;1245;464;2.73;34.42;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
153;110172;Progress in Drug Research;book series;0071786X;0.712;Q1;44;0;57;0;114;51;2.33;0;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q3)"
154;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.707;Q1;95;70;177;2539;386;170;2.01;36.27;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
155;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;0.705;Q1;32;7;38;244;128;35;3.5;34.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
156;14822;Xenobiotica;journal;00498254, 13665928;0.703;Q2;82;73;242;2773;515;240;1.88;37.99;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2); Biochemistry (Q3)"
157;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.699;Q2;81;95;230;2592;472;230;2.08;27.28;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
158;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.697;Q2;52;44;129;1924;229;115;1.72;43.73;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
159;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.695;Q2;112;78;210;3249;376;198;1.72;41.65;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
160;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.692;Q2;50;25;74;1377;192;74;2.35;55.08;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
161;4000150314;Chemical Biology and Drug Design;journal;17470277;0.685;-;82;79;250;2611;423;246;1.73;33.05;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
162;24604;Archives of Toxicology;journal;14320738, 03405761;0.683;Q2;121;90;309;3301;575;305;1.86;36.68;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
163;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.681;Q2;78;42;171;1636;359;168;1.69;38.95;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q3)"
164;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.673;Q2;47;28;109;932;218;107;2.13;33.29;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q2)"
165;18966;Mutagenesis;journal;02678357, 14643804;0.672;Q2;95;67;241;3034;504;234;2.32;45.28;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Genetics (Q3); Genetics (clinical) (Q3)"
166;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.671;Q1;73;37;140;1092;261;130;1.77;29.51;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
167;16533;Phytochemical Analysis;journal;09580344, 10991565;0.668;Q2;76;63;178;1319;263;178;1.36;20.94;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
168;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.662;Q2;87;143;435;5643;735;433;1.75;39.46;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
169;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.662;Q2;92;132;405;5151;683;394;1.56;39.02;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
170;24028;Reproductive Toxicology;journal;08906238, 18731708;0.658;Q2;117;90;201;3730;428;190;1.85;41.44;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
171;23412;Journal of AOAC International;journal;10603271;0.651;Q2;90;192;629;5153;828;628;1.17;26.84;United States;Northern America;AOAC International;1993-2021;"Food Science (Q1); Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
172;21169;Pharmacological Research;journal;10436618, 10961186;0.649;Q2;147;151;472;6695;899;470;1.77;44.34;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q2)
173;19900192900;Molecular Informatics;journal;18681751, 18681743;0.648;Q2;70;78;134;3139;276;131;2.05;40.24;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
174;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.644;Q2;63;79;215;1548;427;188;2.01;19.59;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
175;20783;Expert Review of Vaccines;journal;14760584, 17448395;0.642;Q2;91;105;135;5673;272;125;2.01;54.03;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
176;24785;Alcohol;journal;07418329;0.64;Q2;83;88;219;3902;447;213;1.91;44.34;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2); Behavioral Neuroscience (Q3); Biochemistry (Q3); Neurology (Q3)"
177;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.639;Q2;64;59;173;1418;265;173;1.48;24.03;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
178;16067;Reading Teacher;journal;00340561;0.637;Q2;53;70;242;1782;120;238;0.39;25.46;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.636;Q2;71;70;218;2070;323;181;1.65;29.57;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;25224;Toxicology in Vitro;journal;18793177, 08872333;0.63;Q2;112;107;290;3676;603;288;1.66;34.36;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
181;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.627;Q2;66;44;110;1798;163;107;1.17;40.86;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
182;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.613;Q2;109;120;387;4841;673;309;1.88;40.34;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
183;22410;Inflammation Research;journal;1420908X, 10233830;0.607;Q2;94;168;421;4705;711;416;1.51;28.01;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
184;17067;Phytomedicine;journal;09447113, 1618095X;0.607;Q1;127;104;304;2710;520;294;1.52;26.06;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
185;86329;Mutation Research - Mutation Research Genomics;journal;13835726, 18731341;0.6;Q2;20;0;14;0;30;14;0;0;Netherlands;Western Europe;Elsevier BV;1997-2001;"Toxicology (Q2); Genetics (Q3)"
186;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.599;Q2;54;33;106;1284;226;106;1.8;38.91;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
187;25093;Environmental Toxicology;journal;15227278, 15204081;0.586;Q2;81;82;193;2702;272;190;1.53;32.95;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Toxicology (Q2)"
188;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.583;Q2;77;80;185;2852;344;181;2.05;35.65;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
189;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.582;Q1;124;205;624;7080;1089;619;1.53;34.54;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
190;25864;Heterocycles;journal;03855414;0.58;Q2;66;349;1031;9580;1161;1022;1.14;27.45;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
191;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.578;Q2;90;112;371;2642;455;368;1.19;23.59;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
192;25898;Journal of Peptide Science;journal;10752617, 10991387;0.575;Q2;68;75;208;2688;324;201;1.61;35.84;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Biochemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q3); Molecular Biology (Q4)"
193;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.574;Q2;63;88;218;2594;369;205;1.25;29.48;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
194;33349;Japanese Journal of Pharmacology;journal;13473506, 00215198;0.57;Q2;62;0;371;0;597;368;1.78;0;Japan;Asiatic Region;Japanese Pharmacological Society;1951-2002;Pharmacology (Q2)
195;37409;Anti-Cancer Drug Design;journal;02669536;0.566;Q2;53;0;33;0;56;33;0;0;United States;Northern America;Cognizant Communication Corporation;1985-2001;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3)"
196;18071;Neurotoxicity Research;journal;14763524, 10298428;0.564;Q2;78;62;164;4581;283;160;2.08;73.89;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q2); Neuroscience (miscellaneous) (Q3)"
197;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.56;Q2;64;20;75;602;97;70;0.91;30.1;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
198;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.557;Q2;17;1;11;854;16;11;1.4;854;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q2)
199;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.555;Q2;88;78;142;2882;219;138;1.33;36.95;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
200;25214;Toxicologic Pathology;journal;15331601, 01926233;0.552;Q2;112;115;333;4664;541;312;1.69;40.56;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q4)"
201;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.551;Q2;58;79;108;1956;356;100;3.79;24.76;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
202;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.55;Q2;64;31;102;1248;159;100;1.59;40.26;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
203;25109;Inhalation Toxicology;journal;08958378, 10917691;0.55;Q2;90;105;226;3470;358;222;1.74;33.05;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
204;16573;Phytotherapy Research;journal;10991573, 0951418X;0.549;Q2;140;214;600;5213;810;598;1.21;24.36;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
205;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.548;Q2;93;99;324;3314;487;312;1.44;33.47;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
206;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.54;Q1;122;426;1024;11754;1610;1014;1.57;27.59;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
207;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.537;Q1;81;44;86;1190;161;82;1.44;27.05;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
208;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.537;Q3;50;38;142;1092;252;142;1.79;28.74;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q1); Bioengineering (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
209;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.535;Q2;83;230;532;15724;1090;516;1.99;68.37;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
210;23942;Biomedical Chromatography;journal;10990801, 02693879;0.531;Q2;68;126;241;2708;290;238;1.18;21.49;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Molecular Biology (Q4)"
211;20027;BMC Pharmacology;journal;14712210;0.52;Q2;44;32;50;1245;81;50;1.65;38.91;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
212;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.516;Q3;95;332;1018;7300;1284;1018;1.29;21.99;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
213;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.515;Q2;98;99;292;2277;435;234;1.56;23;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
214;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.514;Q2;76;71;200;1902;299;185;1.17;26.79;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
215;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.512;Q3;64;91;278;2998;354;270;0.98;32.95;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
216;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.493;Q2;42;38;41;3630;67;38;1.55;95.53;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
217;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.492;Q1;61;48;124;1039;199;123;1.2;21.65;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;18077;Fitoterapia;journal;0367326X, 18736971;0.492;Q2;110;147;482;1904;530;482;1.1;12.95;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
219;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.488;Q2;77;117;383;6244;521;375;1.42;53.37;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
220;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.482;Q3;91;75;236;2158;332;234;1.46;28.77;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q3)
221;20634;Journal of Texture Studies;journal;00224901, 17454603;0.482;Q1;57;39;94;1114;103;94;1;28.56;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q1); Food Science (Q2)"
222;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.479;Q3;74;77;199;3559;267;198;1.26;46.22;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
223;24578;Mathematical Medicine and Biology;journal;14778599;0.473;Q2;46;17;50;468;50;49;0.94;27.53;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Applied Mathematics (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
224;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.47;Q2;50;33;101;982;79;101;0.71;29.76;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q4)"
225;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.466;Q3;58;66;78;1626;117;75;1.5;24.64;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q3); Molecular Medicine (Q4)"
226;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;0.465;Q2;33;0;63;0;132;63;1.75;0;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Pharmacology (Q2); Cancer Research (Q3); Oncology (Q3)"
227;21229;Drug News and Perspectives;journal;02140934;0.465;Q2;51;81;218;4026;258;218;1.34;49.7;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Drug Discovery (Q3)"
228;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.465;Q1;62;44;154;1070;131;151;0.79;24.32;United States;Northern America;Informa Healthcare;1996-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2)"
229;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.463;Q3;52;32;44;1500;47;42;1.07;46.88;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
230;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.463;Q2;38;35;69;1316;111;68;1.61;37.6;United States;Northern America;Old City Publishing;1996, 2002-2020;"Pharmacology (Q2); Cancer Research (Q3); Drug Discovery (Q3)"
231;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.461;Q3;52;69;118;1391;92;113;0.74;20.16;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
232;25106;Human and Experimental Toxicology;journal;09603271;0.458;Q3;82;84;328;2540;430;305;1.25;30.24;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
233;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.453;Q1;40;37;130;426;103;93;0.69;11.51;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q1)
234;16088;Journal of Nanobiotechnology;journal;14773155;0.449;Q2;84;12;6;343;12;6;2;28.58;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3); Molecular Medicine (Q4)"
235;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.442;Q3;79;79;185;2309;252;184;1.53;29.23;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
236;20570;Chemotherapy;journal;00093157, 14219794;0.44;Q3;58;60;205;1408;310;197;1.5;23.47;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
237;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.44;Q3;87;204;185;6181;227;180;1.23;30.3;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Pharmacology (Q3); Molecular Medicine (Q4)"
238;4400151608;ChemMedChem;journal;18607187, 18607179;0.435;Q1;106;134;470;3524;594;468;1.19;26.3;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Organic Chemistry (Q3); Molecular Medicine (Q4)"
239;20770;Drug Delivery;journal;10717544, 15210464;0.421;Q2;72;47;100;1044;117;100;1.06;22.21;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
240;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.419;Q3;75;54;99;1699;143;94;1.02;31.46;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q3); Toxicology (Q3)"
241;21265;Drugs of the Future;journal;03778282;0.418;Q3;45;617;264;6554;310;264;0.97;10.62;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
242;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.417;Q2;51;202;689;5028;591;685;0.88;24.89;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
243;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.416;Q3;61;212;219;3633;319;185;1.51;17.14;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
244;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.411;Q3;62;74;198;2280;198;189;1.07;30.81;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q2); Pharmacology (Q3)"
245;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.41;Q3;69;106;280;2278;374;260;1.43;21.49;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
246;21194;Pharmacology;journal;00317012, 14230313;0.406;Q3;60;86;255;2804;295;254;1.14;32.6;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
247;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.405;Q3;76;332;855;5567;578;852;0.63;16.77;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
248;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.398;Q3;48;99;327;1769;313;326;1.09;17.87;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
249;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.397;Q3;99;414;1269;6683;978;653;0.81;16.14;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
250;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.397;Q1;91;235;615;6820;635;610;1;29.02;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
251;23489;Chemical Speciation and Bioavailability;journal;09542299;0.395;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
252;23039;Journal of Liposome Research;journal;08982104, 15322394;0.394;Q2;53;14;87;459;95;81;1.37;32.79;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
253;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.392;Q2;63;71;164;1258;175;143;1.14;17.72;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
254;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.389;Q3;51;25;86;2887;110;83;1.37;115.48;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
255;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.386;Q3;98;260;640;5907;711;640;1.18;22.72;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
256;13671;Biologicals;journal;10958320, 10451056;0.385;Q3;60;28;118;628;144;117;1.08;22.43;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
257;24749;Addiction Biology;journal;13556215, 13691600;0.373;Q3;83;35;141;1064;191;137;1.51;30.4;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q2); Psychiatry and Mental Health (Q2); Pharmacology (Q3)"
258;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.367;Q3;52;174;375;3554;462;340;1.19;20.43;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
259;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.362;Q3;67;110;446;1892;417;419;0.79;17.2;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
260;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.358;Q2;69;55;114;825;90;114;0.79;15;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
261;25144;Journal of Health Science;journal;13475207, 13449702;0.358;Q3;49;105;272;2357;212;272;0.72;22.45;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
262;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.356;Q3;62;53;217;2274;179;193;0.77;42.91;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
263;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.354;Q3;53;54;150;1620;155;150;0.86;30;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
264;20578;Journal of Food and Drug Analysis;journal;10219498;0.352;Q3;63;56;131;1206;97;129;0.69;21.54;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q2); Pharmacology (Q3)"
265;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.351;Q3;20;65;185;175;130;185;0.84;2.69;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
266;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.349;Q2;39;34;107;924;67;105;0.64;27.18;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
267;18005;American Journal of Respiratory Medicine;journal;11756365;0.343;Q3;32;0;93;0;120;87;1.29;0;United Kingdom;Western Europe;Adis International Ltd;2002-2003;"Pulmonary and Respiratory Medicine (Q2); Pharmacology (Q3)"
268;27210;In Vivo;journal;17917549, 0258851X;0.341;Q3;64;110;274;4938;258;273;0.95;44.89;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
269;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.339;Q2;65;75;195;1926;179;194;0.97;25.68;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
270;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.335;Q3;53;79;277;4860;345;276;1.51;61.52;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
271;130063;Pharmacological Reports;journal;17341140;0.335;Q3;87;108;304;3847;320;304;1.05;35.62;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
272;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.328;Q2;52;64;180;2028;141;179;0.71;31.69;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
273;21100470510;Drug Research;journal;21949379, 21949387;0.325;Q3;65;142;398;2767;357;395;0.76;19.49;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
274;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.323;Q3;93;215;439;4253;343;439;0.78;19.78;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
275;16117;Pharmaceutical Biotechnology;journal;10780467;0.323;Q2;27;0;16;0;18;16;1.13;0;United States;Northern America;Kluwer/Plenum Publishers;1993, 1995-1999, 2002;"Pharmaceutical Science (Q2); Applied Microbiology and Biotechnology (Q3)"
276;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.318;Q3;21;14;69;443;49;68;0.71;31.64;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
277;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.315;Q2;57;47;116;1041;105;114;0.96;22.15;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
278;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.315;Q2;36;19;35;604;45;35;1.21;31.79;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
279;40278;Adverse Drug Reactions and Toxicological Reviews;journal;0964198X;0.314;Q3;24;0;40;0;57;30;1.89;0;United Kingdom;Western Europe;Adis International Ltd;1991-2002;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
280;21192;Drug Development Research;journal;02724391, 10982299;0.314;Q3;62;83;370;4489;348;364;0.83;54.08;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
281;73430;Pharmaceutical Technology;journal;15432521;0.307;Q2;38;188;363;707;93;286;0.21;3.76;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
282;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.304;Q3;62;18;99;534;64;97;0.44;29.67;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
283;19374;AAPS PharmSciTech;journal;15309932;0.303;Q2;101;73;147;1543;136;139;0.98;21.14;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Agronomy and Crop Science (Q3); Drug Discovery (Q3); Ecology (Q3); Ecology, Evolution, Behavior and Systematics (Q3); Aquatic Science (Q4)"
284;21717;Die Pharmazie;journal;00317144;0.303;Q2;66;224;691;4146;500;688;0.69;18.51;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
285;21186;Drug Design and Discovery;journal;10559612, 10292322;0.296;Q3;20;0;17;0;12;16;0.75;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
286;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.293;Q2;48;251;804;4715;469;804;0.5;18.78;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
287;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.292;Q3;53;75;291;4638;250;290;0.92;61.84;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
288;26370;Molecules;journal;14203049;0.291;Q2;171;113;363;2741;255;361;0.81;24.26;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Chemistry (miscellaneous) (Q3); Drug Discovery (Q3); Physical and Theoretical Chemistry (Q3); Analytical Chemistry (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
289;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;0.289;Q2;66;89;101;1095;47;57;0.47;12.3;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
290;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.289;Q2;50;74;81;1918;61;79;0.46;25.92;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
291;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.288;Q2;72;124;335;3274;170;333;0.5;26.4;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
292;37381;In Vitro and Molecular Toxicology: Journal of Basic and Applied Research;journal;10979336;0.287;Q3;21;0;23;0;25;20;0;0;United States;Northern America;Mary Ann Liebert Inc.;1996-2001;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
293;25934;Cytokines, Cellular and Molecular Therapy;journal;14660830, 13684736;0.283;Q3;27;0;21;0;24;21;1.14;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2000, 2002;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
294;24097;Journal of the Indian Chemical Society;journal;00194522;0.283;Q3;33;251;677;4841;270;673;0.35;19.29;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q3); Electrochemistry (Q3); Inorganic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Organic Chemistry (Q4)"
295;25189;Reviews in Toxicology;journal;13826980;0.283;Q3;20;0;5;0;5;5;0;0;Netherlands;Western Europe;IOS Press BV;1997-1999, 2001;Toxicology (Q3)
296;22318;Toxicological Reviews;journal;11762551;0.283;Q3;46;23;23;1767;22;22;0.96;76.83;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q3); Toxicology (Q3)"
297;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.28;Q2;65;40;63;1183;76;61;1.21;29.58;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Computer Science Applications (Q3); Nanoscience and Nanotechnology (Q4)"
298;25245;Veterinary and Human Toxicology;journal;01456296;0.279;Q3;41;114;315;1863;188;298;0.57;16.34;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Toxicology (Q3); Veterinary (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q4)"
299;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.276;Q4;41;0;107;0;60;67;0.53;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
300;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.273;Q3;39;30;100;750;97;99;0.85;25;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
301;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.271;Q3;51;80;214;1726;68;204;0.29;21.58;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
302;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.27;Q3;36;18;75;609;43;75;0.45;33.83;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
303;130089;Toxin Reviews;journal;15569543, 15569551;0.267;Q3;46;23;78;1684;55;69;0.59;73.22;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
304;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.264;Q3;21;9;5;367;6;4;1.2;40.78;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q3); Immunology (Q4)"
305;4000148019;AAPS Journal;journal;15507416;0.26;Q2;118;47;219;1001;171;215;0.71;21.3;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q2)
306;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.258;Q3;53;30;98;794;76;97;0.9;26.47;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
307;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.257;Q3;46;30;87;970;61;87;0.72;32.33;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
308;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.256;Q3;16;4;48;323;40;40;0.82;80.75;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q3)
309;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.253;Q3;42;45;249;1214;152;226;0.44;26.98;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
310;94084;Drug Discovery Today: TARGETS;journal;17418372;0.249;Q4;15;64;107;1924;42;88;0.39;30.06;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery (Q4)
311;21102;Pharmaceutical Journal;journal;00316873;0.249;Q2;28;2593;6306;1073;217;688;0.03;0.41;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
312;26767;Altex;journal;1868596X, 18688551;0.248;Q3;57;34;117;795;59;105;0.54;23.38;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
313;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.248;Q2;42;46;142;485;86;142;0.67;10.54;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Analytical Chemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
314;15340;Developments in Biologicals;journal;14246074, 16622960;0.246;Q3;38;67;234;30;134;234;0.52;0.45;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
315;18800156720;Dissolution Technologies;journal;1521298X;0.244;Q2;34;24;42;111;11;23;0.28;4.63;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
316;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.242;Q2;50;63;198;822;61;186;0.22;13.05;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q4); Organic Chemistry (Q4)"
317;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.241;Q3;70;42;183;1692;134;182;0.62;40.29;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
318;34232;Toxicology Methods;journal;10517235;0.234;Q3;18;0;21;0;15;21;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2001;Toxicology (Q3)
319;21264;Drugs in R and D;journal;11796901, 11745886;0.232;Q3;47;66;164;1050;113;146;0.69;15.91;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
320;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.23;Q3;39;38;123;767;60;123;0.45;20.18;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
321;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.229;Q3;53;68;223;1570;105;175;0.41;23.09;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
322;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.229;Q2;31;17;51;472;57;51;0.65;27.76;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
323;79053;Natural Product Sciences;journal;12263907;0.228;Q4;28;67;131;1554;52;131;0.43;23.19;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
324;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.227;Q3;48;35;80;1017;92;71;1;29.06;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4)"
325;13718;Pharmaceutical Engineering;journal;02738139;0.227;Q2;16;52;135;394;27;135;0.2;7.58;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q2)
326;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.224;Q2;15;43;11;543;5;10;0.45;12.63;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q2)
327;22881;Yaoxue Xuebao;journal;05134870;0.224;Q2;34;231;680;2563;203;678;0.3;11.1;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
328;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.222;Q2;69;118;244;1724;123;239;0.46;14.61;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
329;20065;BioPharm International;trade journal;1542166X, 19391862;0.222;Q2;29;119;363;576;61;317;0.22;4.84;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
330;25253;Blutalkohol (discontinued);journal;00065250;0.221;Q4;13;35;65;779;12;63;0.17;22.26;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q4)"
331;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.221;Q3;24;37;197;750;73;197;0.32;20.27;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
332;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.217;Q2;66;28;113;958;77;110;0.7;34.21;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Dermatology (Q3); Colloid and Surface Chemistry (Q4); Drug Discovery (Q4)"
333;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.216;Q4;48;17;29;2216;24;29;3;130.35;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q4); Toxicology (Q4)"
334;24659;Comments on Toxicology;journal;08865140;0.214;Q4;12;0;59;0;20;51;0.23;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q4)
335;22375;Indian Drugs;journal;0019462X;0.212;Q2;31;140;405;1903;81;401;0.2;13.59;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3); Drug Discovery (Q4)"
336;24071;Metal-Based Drugs;journal;07930291, 16875486;0.212;Q3;38;0;60;0;65;60;0.5;0;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q3); Drug Discovery (Q4); Inorganic Chemistry (Q4); Toxicology (Q4)"
337;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.21;Q3;62;125;238;1566;94;147;0.35;12.53;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
338;25171;Mycotoxin Research;journal;18671632, 01787888;0.21;Q4;40;13;169;191;30;169;0.15;14.69;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q4); Toxicology (Q4)"
339;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.208;Q3;19;226;645;743;73;639;0.11;3.29;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
340;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.207;Q3;9;38;152;511;44;130;0.26;13.45;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
341;21211;Pharmacy Education;journal;14772701, 15602214;0.207;Q3;18;28;70;307;20;68;0.29;10.96;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q2); Education (Q3); Pharmaceutical Science (Q3)"
342;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.205;Q3;20;0;106;0;34;88;0.33;0;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q2); Pharmaceutical Science (Q3)"
343;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.205;Q4;46;50;58;1748;36;56;0.62;34.96;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
344;19446;American Pharmaceutical Review;journal;10998012;0.204;Q3;24;95;142;1244;68;124;0.48;13.09;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
345;22906;Journal of China Pharmaceutical University;journal;10005048;0.204;Q3;14;145;280;1276;39;280;0.14;8.8;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
346;23155;Current Vascular Pharmacology;journal;15701611, 18756212;0.202;Q3;63;37;33;4393;16;33;0.48;118.73;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (Q3)"
347;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.201;Q3;15;0;54;0;28;54;0.5;0;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
348;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.201;Q3;39;23;128;537;72;128;0.04;23.35;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Molecular Medicine (Q4)"
349;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.2;Q3;29;28;81;608;15;78;0.12;21.71;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
350;21496;Revista de Chimie (discontinued);journal;00347752;0.2;-;31;229;537;3497;123;536;0.27;15.27;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
351;20564;Ceska a Slovenska Farmacie;journal;12107816;0.199;Q3;17;60;157;1965;45;156;0.3;32.75;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
352;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.198;Q4;37;31;87;950;16;86;0.13;30.65;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
353;16836;BMC Chemical Biology;journal;14726769;0.197;Q4;20;2;6;77;2;6;0;38.5;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q4); Molecular Medicine (Q4)"
354;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.196;Q3;46;26;105;454;25;104;0.19;17.46;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q3)
355;22411;Inflammopharmacology;journal;09254692, 15685608;0.194;Q3;55;34;107;1069;52;105;0.47;31.44;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
356;21798;Farmaceutski Glasnik;journal;00148202;0.192;Q3;6;17;53;448;12;53;0.22;26.35;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
357;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.19;Q3;6;25;84;383;13;71;0.23;15.32;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
358;20661;Current Drug Discovery;journal;14727463;0.19;Q3;12;97;304;0;57;181;0.19;0;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology (Q3)
359;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.188;Q4;39;16;61;259;10;61;0.27;16.19;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
360;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.187;Q3;61;163;381;3152;79;381;0.15;19.34;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q3)
361;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.186;Q4;38;0;189;0;62;187;0.17;0;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q4); Biochemistry (Q4); Bioengineering (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
362;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.185;Q3;45;110;247;1568;105;247;0.38;14.25;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
363;21127;Pharmaceutical Technology Europe;journal;01646826;0.185;Q3;18;67;215;408;26;118;0.06;6.09;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
364;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0.18;Q4;17;45;36;1250;14;29;0.39;27.78;Netherlands;Western Europe;Elsevier BV;2003-2004;Drug Discovery (Q4)
365;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.177;Q3;14;27;117;813;19;117;0.18;30.11;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
366;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.172;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
367;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.168;Q3;29;23;95;489;23;84;0.3;21.26;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
368;91481;Pharmacology Reviews and Communications;journal;10288945;0.168;Q3;9;0;49;0;17;49;0.52;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2002;Pharmacology (Q3)
369;22205;Saudi Pharmaceutical Journal;journal;13190164;0.168;Q3;57;24;79;611;16;76;0.06;25.46;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
370;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.166;Q3;35;205;465;2716;138;464;0.27;13.25;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
371;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.166;Q3;19;54;105;705;18;88;0.2;13.06;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q4)"
372;23055;Journal of Natural Toxins;journal;10588108;0.165;Q4;26;0;76;0;40;76;0.55;0;United States;Northern America;Alaken Inc.;1996-2002;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
373;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.163;Q3;19;88;384;2620;103;362;0.27;29.77;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q3)
374;21077;Pharmaca;journal;00316857;0.162;Q3;5;9;24;357;5;24;0.17;39.67;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
375;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.161;Q3;7;20;84;444;6;84;0.11;22.2;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
376;21142;Pharmaceutisch Weekblad;journal;00316911;0.161;Q3;9;514;1318;2500;121;996;0.1;4.86;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
377;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.157;Q3;40;33;20;3598;8;20;0.4;109.03;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Hematology (Q4)"
378;17700156431;Handbook of Analytical Separations;book series;15677192;0.156;Q3;12;14;27;1587;9;10;0.33;113.36;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4)"
379;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.155;Q3;27;51;163;1295;55;155;0.37;25.39;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
380;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.155;Q3;19;14;32;307;12;32;0.52;21.93;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
381;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.155;Q3;18;38;42;1089;8;41;0.12;28.66;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
382;23171;Korean Journal of Pharmacognosy;journal;02533073;0.154;Q3;17;65;174;1325;22;174;0.09;20.38;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
383;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.151;Q3;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Clinical Psychology (Q4); Psychiatry and Mental Health (Q4)"
384;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.15;Q3;60;32;105;706;31;105;0.3;22.06;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (Q3)"
385;21758;Prescrire International;journal;11677422;0.15;Q4;13;141;394;1299;121;220;0.31;9.21;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
386;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.149;Q3;10;35;27;1325;2;26;0.04;37.86;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4)"
387;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.148;Q4;19;27;114;574;17;79;0.13;21.26;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
388;20543;Pharmacometrics;journal;03008533;0.145;Q3;6;33;61;634;14;61;0.09;19.21;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
389;35190;Revista Espanola de Quimioterapia;journal;02143429;0.144;Q4;26;46;142;1604;52;128;0.3;34.87;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q4)"
390;22338;Hospital Pharmacy;journal;19451253, 00185787;0.142;Q4;24;139;479;1835;54;396;0.13;13.2;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
391;21716;Pharmazeutische Zeitung;journal;00317136;0.142;Q4;7;475;1290;1196;16;635;0.01;2.52;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
392;25197;Revista de Toxicologia (discontinued);journal;02127113;0.142;Q4;11;16;64;759;11;63;0.17;47.44;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
393;16893;Biogenic Amines;journal;15693910, 01688561;0.139;Q4;15;32;79;1652;18;77;0.35;51.63;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
394;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.139;Q3;43;61;177;1834;17;167;0.1;30.07;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
395;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.139;Q4;19;13;47;354;16;40;0.41;27.23;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q4)"
396;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.139;Q3;10;45;136;231;15;133;0.14;5.13;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
397;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.139;Q3;43;99;313;3614;112;313;0.33;36.51;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
398;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.136;Q4;24;81;169;1714;44;133;0.28;21.16;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
399;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.135;Q4;16;76;348;1097;19;343;0.04;14.43;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
400;52649;Pharmaceutical and Pharmacological Letters;journal;09399488;0.135;Q3;17;0;27;0;9;27;0;0;Germany;Western Europe;Stuttgart Medpharm Scientific Publishers;1996-2001;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
401;20572;PZ Prisma;journal;09455566;0.133;Q3;5;35;92;710;7;80;0.09;20.29;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
402;69108;Chemotherapie Journal, Supplement;journal;09446486;0.131;Q4;6;0;29;0;4;28;0.17;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
403;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.13;Q4;6;6;45;119;6;45;0.17;19.83;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q4); Pharmacology (Q4)"
404;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.13;Q4;13;49;136;779;15;103;0.11;15.9;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
405;22979;Journal of Applied Therapeutic Research;journal;10292659;0.129;Q4;8;19;18;388;4;18;0.22;20.42;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
406;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.129;Q3;13;41;149;940;22;94;0.2;22.93;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q3)
407;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.128;Q4;22;34;69;701;10;69;0.14;20.62;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
408;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.128;Q4;14;0;40;0;3;40;0;0;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
409;19700180757;Advances in Phytomedicine;book series;1572557X;0.127;Q4;13;0;29;0;4;0;0.14;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
410;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.127;Q4;32;27;71;740;9;68;0.18;27.41;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
411;62531;Pharmaceutical News;journal;1071894X;0.127;Q3;11;0;138;0;32;120;0.33;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2002;Pharmaceutical Science (Q3)
412;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.127;Q3;32;281;633;2763;78;633;0.13;9.83;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
413;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.126;Q3;23;7;7;195;4;5;0.57;27.86;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
414;86688;Acta Toxicologica;journal;17316383;0.125;Q4;7;18;17;585;2;15;0.12;32.5;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
415;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.125;Q4;4;24;188;672;5;188;0.02;28;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
416;15842;Journal of Applied Research;journal;1537064X;0.124;Q4;22;76;104;1861;24;104;0.22;24.49;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
417;97159;Journal of Research in Pharmaceutical Economics;journal;08966621;0.124;Q4;5;0;30;0;4;24;0;0;United States;Northern America;Pharmaceutical Products Press;1996-1998, 2000-2001;"Health Policy (Q4); Pharmaceutical Science (Q4)"
418;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.124;Q4;13;70;231;886;22;200;0.11;12.66;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
419;72755;Phytomedica;journal;09723293;0.124;Q4;4;21;47;266;3;47;0;12.67;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
420;17716;Quality Assurance Journal;journal;10991786, 10878378;0.124;Q4;9;35;82;165;9;69;0.11;4.71;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
421;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.123;Q4;20;27;94;468;13;94;0.14;17.33;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
422;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.123;Q4;12;89;262;1431;30;261;0.11;16.08;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
423;23009;Journal of Clinical Research;journal;13695207;0.122;Q4;11;1;14;23;8;14;0.5;23;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
424;130031;Journal of Toxicologic Pathology;journal;09149198;0.122;Q4;30;39;83;1046;11;83;0.2;26.82;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
425;22934;Chinese Pharmaceutical Journal;journal;10012494;0.121;Q4;21;322;961;3591;86;961;0.09;11.15;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
426;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.121;Q4;11;48;38;1570;10;38;0.26;32.71;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
427;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.121;Q4;46;88;511;1751;155;499;0.29;19.9;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
428;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.119;Q4;7;6;17;270;2;17;0;45;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
429;22514;Japanese Journal of Chemotherapy;journal;13407007;0.119;Q4;12;55;246;936;42;245;0.2;17.02;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
430;19700180737;Pharmacochemistry Library;journal;01657208;0.119;Q4;10;0;25;0;3;23;0.12;0;Netherlands;Western Europe;Elsevier;1995-1998, 2000, 2002;"Drug Discovery (Q4); Organic Chemistry (Q4); Pharmacology (Q4)"
431;21867;Geneesmiddelenbulletin;journal;03044629;0.118;Q4;7;52;223;180;11;35;0.06;3.46;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
432;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.118;Q4;7;0;50;0;8;50;0.13;0;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
433;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.117;-;12;0;5;0;1;5;0.2;0;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q3)
434;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.117;Q4;6;42;70;296;2;37;0.03;7.05;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
435;15892;Journal of Drug Evaluation;journal;14791137;0.116;Q4;4;24;21;1440;1;9;0.05;60;United Kingdom;Western Europe;Parthenon Publishing Group;2003-2004;"Pharmacy (Q3); Pharmacology (Q4)"
436;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.115;Q4;11;21;34;639;3;34;0.09;30.43;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
437;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.115;Q4;9;11;26;435;5;26;0;39.55;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
438;22908;Chinese Pharmacological Bulletin;journal;10011978;0.115;Q4;17;386;844;4662;72;844;0.07;12.08;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
439;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.115;Q4;47;32;84;693;11;83;0.11;21.66;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
440;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.115;Q4;18;39;38;1254;4;37;0.08;32.15;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
441;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.115;Q4;33;52;170;1715;14;170;0.08;32.98;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
442;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.114;Q4;11;26;40;274;3;29;0.1;10.54;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
443;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.114;Q4;5;17;48;303;1;48;0;17.82;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
444;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.114;Q4;34;160;548;3073;12;545;0.02;19.21;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
445;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.113;Q4;29;7;139;875;28;137;0.13;125;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
446;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.113;Q4;9;29;104;719;5;87;0.06;24.79;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
447;21823;Pharmacia;journal;04280296;0.112;Q4;16;12;34;305;1;32;0.04;25.42;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
448;21227;Pharmacy in Practice;journal;13581538;0.112;Q4;5;62;97;352;4;79;0.06;5.68;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
449;19407;Acta Poloniae Toxicologica;journal;12306967;0.111;Q4;4;0;40;0;5;40;0.22;0;Poland;Eastern Europe;Polskie Towarzystwo Toksykologiczne/Polish Society of Toxicology;1999-2002;Toxicology (Q4)
450;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.111;Q4;15;115;384;1999;32;384;0.09;17.38;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
451;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.11;Q4;5;17;16;19;2;16;0;1.12;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
452;110097;Food and Drug Law Journal;journal;1064590X;0.108;Q4;22;38;99;1112;16;96;0.11;29.26;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Public Health, Environmental and Occupational Health (Q4)"
453;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.107;Q4;2;1;3;79;0;3;0;79;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
454;22977;Journal de Pharmacie de Belgique;journal;00472166;0.107;Q4;12;22;64;384;4;64;0.07;17.45;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
455;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.107;Q4;14;20;64;42;8;64;0.12;2.1;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
456;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.106;Q4;12;0;7;0;1;7;0.14;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Infectious Diseases (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Virology (Q4)"
457;145693;Canadian Pharmacists Journal;journal;17151635;0.106;Q4;24;138;358;800;7;260;0.03;5.8;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
458;19700175108;Drug Delivery System;journal;18812732, 09135006;0.106;Q4;8;37;94;615;2;94;0.02;16.62;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
459;19700180810;Alkaloids: Chemical and Biological Perspectives;book series;07358210;0.105;Q4;14;0;6;0;0;4;0;0;Netherlands;Western Europe;Elsevier;1996, 1998-1999, 2001;"Drug Discovery (Q4); Organic Chemistry (Q4)"
460;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.105;Q4;20;24;32;710;8;32;0.29;29.58;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
461;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.105;-;31;50;116;853;6;108;0.04;17.06;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
462;21813;Research Communications in Alcohol and Substances of Abuse;journal;10808388;0.105;Q4;5;0;4;0;0;4;0;0;United States;Northern America;PJD Publications Ltd;1994-1999, 2001;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
463;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.103;Q4;28;16;131;0;8;131;0.15;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
464;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.103;Q4;35;90;165;1095;2;147;0.01;12.17;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
465;22887;Chinese Journal of Antibiotics;journal;10018689;0.102;Q4;11;205;435;1932;8;420;0.02;9.42;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
466;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.102;Q4;17;15;99;508;5;94;0.07;33.87;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
467;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.102;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
468;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.102;Q4;34;14;85;0;1;85;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
469;72763;Drugs Made in Germany;journal;00126683;0.102;Q4;4;0;29;0;1;29;0;0;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1964, 1973-2002;"Molecular Medicine (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
470;21329;European Journal of Herbal Medicine;journal;13524755;0.102;Q4;2;5;23;46;1;14;0;9.2;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
471;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.102;Q4;8;0;52;0;1;52;0.03;0;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
472;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.102;Q4;7;55;148;723;8;130;0.05;13.15;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
473;94039;Journal of Managed Pharmaceutical Care;journal;15349721, 15349713;0.102;Q4;3;0;35;0;1;34;0;0;United States;Northern America;Pharmaceutical Products Press;2001;"Leadership and Management (Q4); Pharmacology (Q4)"
474;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.102;Q4;21;0;39;0;3;21;0;0;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
475;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;628;1008;0;16;820;0.01;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
476;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.101;Q4;5;13;35;508;0;35;0;39.08;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
477;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;0;18;0;0;18;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
478;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.101;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
479;22365;International Antiviral News;journal;09652310;0.101;Q4;8;0;25;0;0;23;0;0;United Kingdom;Western Europe;International Medical Press Ltd;1994-2001;"Pharmacology (Q4); Virology (Q4)"
480;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;18;25;219;0;24;0;12.17;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
481;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.101;Q4;7;20;20;450;1;19;0.05;22.5;United States;Northern America;Haworth Press Inc.;2003-2008;"Health Policy (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
482;13637;Manufacturing Chemist;trade journal;02624230;0.101;Q4;6;0;906;0;0;18;0;0;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
483;79249;Modern Drug Discovery;journal;10998209;0.101;Q4;9;0;19;0;0;19;0;0;United States;Northern America;American Chemical Society;1998-2001;Pharmaceutical Science (Q4)
484;63560;Pharmaceutical Visions;journal;09661719;0.101;Q4;1;0;28;0;2;27;0;0;United Kingdom;Western Europe;London Monarch Communications;1997-2001;Pharmaceutical Science (Q4)
485;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.101;Q4;8;0;17;0;0;16;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
486;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;9;34;15;470;0;15;0;13.82;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
487;21837;Revista Portuguesa de Farmacia;journal;0484811X;0.101;Q4;5;0;21;0;1;21;0;0;Portugal;Western Europe;Ordem dos Farmaceuticos;1961, 1990-2001;Pharmaceutical Science (Q4)
488;5800207507;Side Effects of Drugs Annual;book series;03786080;0.101;Q4;6;51;155;3205;2;155;0.01;62.84;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
489;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;150;315;275;3;259;0.01;1.83;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
490;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.1;Q4;6;46;111;88;1;111;0;1.91;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
491;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;36;94;190;1;82;0.02;5.28;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
492;59522;Current Therapeutics;journal;0311905X;0.1;Q4;5;0;263;0;2;186;0.01;0;Australia;Pacific Region;ADIS Press;1974-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
493;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;102;199;226;4;143;0.02;2.22;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
494;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.1;Q4;3;14;43;186;0;40;0;13.29;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
495;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;23;91;296;0;84;0;12.87;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
496;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.1;Q4;9;0;48;0;2;44;0;0;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
497;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.1;Q4;6;0;58;0;0;58;0;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
498;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.1;Q4;10;0;39;0;1;39;0.08;0;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
499;25196;Revista Brasileira de Toxicologia;journal;14152983;0.1;Q4;7;11;50;333;1;44;0.03;30.27;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
500;9500153934;Therapiewoche;journal;02566869;0.1;Q4;1;0;57;0;0;51;0;0;Austria;Western Europe;Therapiewoche Verlag;2000-2002;Pharmacology (Q4)
501;19427;Advances in Pharmacology;journal;15578925, 10543589;;-;78;34;0;2683;0;0;0;78.91;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous); Pharmacology"
502;19441;American Journal of Drug Delivery;journal;11759038;;-;22;20;0;1951;0;0;0;97.55;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology
503;21100218041;Anti-Infective Agents;journal;22113533, 22113525;;-;24;24;0;2699;0;0;0;112.46;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases; Pharmacology"
504;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;;-;24;31;0;4684;0;0;0;151.1;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Immunology; Immunology and Allergy; Medicine (miscellaneous); Pharmacology"
505;59665;Chinese Journal of Natural Medicines;journal;16723651;;-;40;89;0;1164;0;0;0;13.08;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine; Drug Discovery; Medicine (miscellaneous)"
506;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;;-;14;44;0;513;0;0;0;11.66;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography; Environmental Science (miscellaneous); Toxicology"
507;144771;Clinical Trials;journal;17407753, 17407745;;-;67;60;0;1424;0;0;0;23.73;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous); Pharmacology"
508;130025;Current Drug Delivery;journal;15672018;;-;65;38;0;2243;0;0;0;59.03;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science
509;130047;Current Drug Discovery Technologies;journal;15701638;;-;44;24;0;1598;0;0;0;66.58;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery
510;25466;Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents;journal;15680134;;-;10;36;0;2776;0;0;0;77.11;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2005;"Endocrinology, Diabetes and Metabolism; Immunology and Allergy; Pharmacology"
511;14990;Current Neuropharmacology;journal;18756190, 1570159X;;-;82;32;0;4283;0;0;0;133.84;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous); Neurology; Neurology (clinical); Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
512;20684;Current Pharmacogenomics;journal;15701603;;-;12;32;0;3660;0;0;0;114.38;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Genetics; Pharmacology"
513;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;;-;27;65;0;2319;0;0;0;35.68;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery; Molecular Medicine"
514;144963;Drug Discovery Today: Disease Models;journal;17406757;;-;28;64;0;2365;0;0;0;36.95;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery; Molecular Medicine"
515;21207;Drug Discovery Today: Technologies;journal;17406749;;-;53;62;0;1799;0;0;0;29.02;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology; Drug Discovery; Molecular Medicine"
516;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;;-;29;74;0;2743;0;0;0;37.07;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery; Molecular Medicine; Pharmacology"
517;73076;Drug Discovery World;journal;14694344;;-;13;10;0;146;0;0;0;14.6;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery
518;50087;EBR - European Biopharmaceutical Review;journal;13690663;;-;5;105;0;454;0;0;0;4.32;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science
519;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;;-;6;16;0;684;0;0;0;42.75;France;Western Europe;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health; Toxicology"
520;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;18;36;454;30;35;0.3;25.22;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
521;84948;Expert Opinion on Drug Delivery;journal;17425247;;-;116;16;0;1304;0;0;0;81.5;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science
522;4000148203;Handbook of Experimental Pharmacology;journal;01712004;;-;96;1;0;151;0;0;0;151;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
523;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;;-;2;17;0;2762;0;0;0;162.47;Netherlands;Western Europe;Elsevier;2004;"Immunology; Toxicology"
524;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;43;63;893;4;60;0.06;20.77;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
525;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;;-;39;1;0;9;0;0;0;9;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science
526;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;11;63;101;8;61;0.13;9.18;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
527;21281;Journal of Immunotherapy;journal;10538550;;-;46;3;91;130;309;90;3.07;43.33;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2004;"Cancer Research; Immunology; Pharmacology"
528;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;;-;40;11;0;919;0;0;0;83.55;United States;Northern America;Informa Healthcare;2004-2021;"Immunology; Toxicology"
529;80593;Journal of Medicinal Plants;journal;16840240;;-;23;36;0;822;0;0;0;22.83;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine; Pharmacology"
530;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;;-;12;40;0;1161;0;0;0;29.03;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine; Drug Discovery"
531;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;91;142;1935;31;142;0.2;21.26;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
532;144790;Marine Drugs;journal;16603397;;-;128;19;8;572;2;6;0.25;30.11;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery
533;130126;Molecular Pharmaceutics;journal;15438384, 15438392;;-;138;57;0;0;0;0;0;0;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
534;145096;Neuropsychopharmacologia Hungarica;journal;14198711;;-;17;32;0;547;0;0;0;17.09;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Neurology (clinical); Neuropsychology and Physiological Psychology; Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
535;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;7;57;20;16;54;0.34;2.86;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
536;5100155080;Neurotherapeutics;journal;19337213;;-;122;51;0;4216;0;0;0;82.67;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical); Pharmacology; Pharmacology (medical)"
537;4400151524;Particle and Fibre Toxicology;journal;17438977;;-;105;3;0;78;0;0;0;26;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis; Medicine (miscellaneous); Toxicology"
538;58808;Pharmaceutical Care and Research;journal;16712838;;-;8;116;0;1012;0;0;0;8.72;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Drug Discovery; Pharmaceutical Science; Pharmacology"
539;17700156714;Pharmaceuticals;journal;14248247;;-;69;3;0;34;0;0;0;11.33;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
540;21124;Pharmaceutical Statistics;journal;15391612, 15391604;;-;39;32;0;508;0;0;0;15.88;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology; Pharmacology (medical); Statistics and Probability"
541;89630;Psychopharmakotherapie, Supplement;journal;09465146;;-;2;7;0;0;0;0;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology; Psychiatry and Mental Health"
542;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;;-;10;32;0;2202;0;0;0;68.81;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery; Organic Chemistry"
